Cellulite Global Clinical Trials Review, H2, 2018

2018-12-31
Cellulite Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Cellulite Global Clinical Trials Review, H2, 2018” provides an overview of Cellulite clinical trials scenario. This report provides...

Cholangitis Global Clinical Trials Review, H2, 2018

2018-12-31
Cholangitis Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Cholangitis Global Clinical Trials Review, H2, 2018” provides an overview of Cholangitis clinical trials scenario. This report...

Brucellosis Global Clinical Trials Review, H2, 2018

2018-12-31
Brucellosis Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Brucellosis Global Clinical Trials Review, H2, 2018” provides an overview of Brucellosis clinical trials scenario. This report...

Cellulitis Global Clinical Trials Review, H2, 2018

2018-12-31
Cellulitis Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Cellulitis Global Clinical Trials Review, H2, 2018” provides an overview of Cellulitis clinical trials scenario. This report provides...

Cholecystitis Global Clinical Trials Review, H2, 2018

2018-12-31
Cholecystitis Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Cholecystitis Global Clinical Trials Review, H2, 2018” provides an overview of Cholecystitis clinical trials scenario. This...

Competitor Landscape: Sjogren’s Syndrome

2018-12-30
Competitor Landscape: Sjögren’s Syndrome Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Sjögren’s Syndrome market, analysis of current & potential future...

Vaccines for Emerging Infectious Diseases: Funding, R&D, and Global Partnership Strategies

2018-12-11
Vaccines for Emerging Infectious Diseases: Funding, R&D, and Global Partnership Strategies Summary Emerging infectious diseases (EIDs) are characterized by unpredictable incidence and clinical patterns that pose unique challenges for vaccine...

PharmSource – Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars – 2018 Edition

2018-12-03
PharmSource – Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars – 2018 Edition Summary Biosimilars are drugs that are highly similar but not identical to branded “innovator” biologics: large molecule,...

EU5 Hydrocephalus Shunting Procedures Outlook to 2025

2018-12-01
EU5 Hydrocephalus Shunting Procedures Outlook to 2025 Summary GlobalData’s new report, EU5 Hydrocephalus Shunting Procedures Outlook to 2025, provides key procedures data on the EU5 Hydrocephalus Shunting Procedures. The report provides...

Spain Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others

2018-12-01
Spain Neurology Procedures Outlook to 2025 – Hydrocephalus Shunting Procedures, Neurovascular Thrombectomy Procedures, ICP Procedures and Others Summary GlobalData’s new report, Spain Neurology Procedures Outlook to 2025, provides...
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy